Global Digital Biology Market by Type (Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software), By Application (In-house, Contract) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Digital Biology Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Digital Biology Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Digital Biology Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Digital Biology Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Digital Biology Market Size & Forecast, 2018-2028
4.5.1 Digital Biology Market Size and Y-o-Y Growth
4.5.2 Digital Biology Market Absolute $ Opportunity
Chapter 5 Global Digital Biology Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Digital Biology Market Size Forecast by Type
5.2.1 Cellular & Biological Simulation
5.2.2 Drug Discovery & Disease Modelling
5.2.3 Preclinical Drug Development
5.2.4 Clinical Trials
5.2.5 Human Body Simulation Software
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Digital Biology Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Digital Biology Market Size Forecast by Applications
6.2.1 In-house
6.2.2 Contract
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Digital Biology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Digital Biology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Digital Biology Analysis and Forecast
9.1 Introduction
9.2 North America Digital Biology Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Digital Biology Market Size Forecast by Type
9.6.1 Cellular & Biological Simulation
9.6.2 Drug Discovery & Disease Modelling
9.6.3 Preclinical Drug Development
9.6.4 Clinical Trials
9.6.5 Human Body Simulation Software
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Digital Biology Market Size Forecast by Applications
9.10.1 In-house
9.10.2 Contract
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Digital Biology Analysis and Forecast
10.1 Introduction
10.2 Europe Digital Biology Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Digital Biology Market Size Forecast by Type
10.6.1 Cellular & Biological Simulation
10.6.2 Drug Discovery & Disease Modelling
10.6.3 Preclinical Drug Development
10.6.4 Clinical Trials
10.6.5 Human Body Simulation Software
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Digital Biology Market Size Forecast by Applications
10.10.1 In-house
10.10.2 Contract
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Digital Biology Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Digital Biology Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Digital Biology Market Size Forecast by Type
11.6.1 Cellular & Biological Simulation
11.6.2 Drug Discovery & Disease Modelling
11.6.3 Preclinical Drug Development
11.6.4 Clinical Trials
11.6.5 Human Body Simulation Software
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Digital Biology Market Size Forecast by Applications
11.10.1 In-house
11.10.2 Contract
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Digital Biology Analysis and Forecast
12.1 Introduction
12.2 Latin America Digital Biology Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Digital Biology Market Size Forecast by Type
12.6.1 Cellular & Biological Simulation
12.6.2 Drug Discovery & Disease Modelling
12.6.3 Preclinical Drug Development
12.6.4 Clinical Trials
12.6.5 Human Body Simulation Software
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Digital Biology Market Size Forecast by Applications
12.10.1 In-house
12.10.2 Contract
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Digital Biology Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Digital Biology Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Digital Biology Market Size Forecast by Type
13.6.1 Cellular & Biological Simulation
13.6.2 Drug Discovery & Disease Modelling
13.6.3 Preclinical Drug Development
13.6.4 Clinical Trials
13.6.5 Human Body Simulation Software
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Digital Biology Market Size Forecast by Applications
13.10.1 In-house
13.10.2 Contract
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Digital Biology Market: Competitive Dashboard
14.2 Global Digital Biology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 DUNA Bioinformatics
14.3.2 Precigen (Intrexon Corporation)
14.3.3 Dassault Systèmes
14.3.4 Genedata AG
14.3.5 Simulations Plus, Inc.